A Step towards Personalised Cancer Treatment in Lower Middle-income Countries (LMICS): Molecular Tumour Boards

Agha Muhammad Hammad Khan, Ikram Burney, Zeeshan Ansar, Ahmed Nadeem Abbasi

Research output: Contribution to journalReview articlepeer-review

Abstract

Tumour boards are meetings where physicians from various disciplines treating cancer patients meet to recommend evidence-based or the best possible treatment plan. These meetings have evolved with time and now, in every part of the world; site-specific multi-disciplinary tumour boards are established. These meetings are considered pivotal for improving patient outcomes. The advances in molecular and genetic knowledge and technique and their integration in treatment options have paved the way for multiple therapeutic options. However, the adoption of personalised treatment choices is associated with a huge financial burden, especially in low and middle-income countries (LMICs). A molecular tumour board can help to identify and suggest the most appropriate plan of management.

Original languageEnglish
Pages (from-to)1070-1072
Number of pages3
JournalJournal of the College of Physicians and Surgeons--Pakistan : JCPSP
Volume33
Issue number9
DOIs
Publication statusPublished - Sept 2023

Keywords

  • Challenges
  • Genetics
  • Molecular
  • Personalised

Fingerprint

Dive into the research topics of 'A Step towards Personalised Cancer Treatment in Lower Middle-income Countries (LMICS): Molecular Tumour Boards'. Together they form a unique fingerprint.

Cite this